FDA Misgivings About Reprints Would Not Make Them "False" - WLF Lawyer
This article was originally published in The Gray Sheet
Executive Summary
FDA would not be permitted to object to off-label reprints as "false and misleading" because the agency has technical problems with an article under the recent Washington Legal Foundation v. Henney ruling on off-label dissemination, Daniel Troy of the Washington D.C. law firm of Wiley, Rein & Fielding, asserted.